Applicant, as named in the Orange Book

Organon Llc

Next listed expiry: Xaciato on 22 Sep 2036. 2 products with live protection, 6 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xaciato clindamycin phosphate	clindamycin phosphate	215650	22 Sep 2036	patent
Vtama tapinarof	tapinarof	215272	18 Dec 2039	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (6)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Asmanex Hfa · 3 strengths mometasone furoate	mometasone furoate	205641	open now	no listed protection
Asmanex Twisthaler · 2 strengths mometasone furoate	mometasone furoate	021067	open now	no listed protection
Clarinex-D 12 Hour desloratadine; pseudoephedrine sulfate	desloratadine; pseudoephedrine sulfate	021313	open now	no listed protection
Dulera · 3 strengths formoterol fumarate; mometasone furoate	formoterol fumarate; mometasone furoate	022518	open now	no listed protection
Fosamax Plus D · 2 strengths alendronate sodium; cholecalciferol	alendronate sodium; cholecalciferol	021762	open now	no listed protection
Maxalt rizatriptan benzoate	rizatriptan benzoate	020864	open now	no listed protection